Recall of Drug in India and United Kingdom: A Comparative Review
Abstract
Recall is the action which is taken to withdraw drug from distribution. If the product is defected in terms of quality, safety, efficacy. Recall can be voluntary or statutory recall. There are different classes of recall based on severity of the recall. In India recall is guided by CDSCO where as in UK done by MHRA (medicines and healthcare products regulatory agency). There are three levels of recall which can be done at consumer, retail, wholesale. Distributors and healthcare professionals play important role in recall of drug. Generally, company initiate the recall with the help of regulatory authorities, distributors and healthcare professionals. Recall is carried out by using different steps with the help of Drug Inspector, marketing company and investigational team. In this review, we are mainly focusing on comparison of recall in regulatory authorities of India and United Kingdom, in terms of level, classes of recall and their similarities and differences.
Downloads
References
https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
2. Central Drugs Standard Control Organization. Guidelines on Recall and Rapid Alert System for Drugs (Including biologicals & vaccines) [Internet]. CDSCO; 2012 Nov [cited 2024 Oct 29]. Available from:
https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/biologicals/4GuidelineRecalRapidAlert.pdf
3. Drug recalls and market withdrawals [Internet]. 2024 [cited 2024 Oct 29]. Available from:
http://www.hsc.unm.edu/pharmacy/docs/Pharmacy101forIPPEpreceptorkey.pdf
4. Farrukh MJ, Tariq MH, Malik O, Khan TM. Valsartan recall: global regulatory overview and future challenges. Therapeutic Advances in Drug Safety. 2019;10.
doi:10.1177/2042098618823458
5. Cheng M, Organization WH. Medical device regulations: Global Overview and Guiding Principles. World Health Organization; 2003.
6. Micklitz HW, Saumier G. Enforcement and effectiveness of consumer law. Seiter A. A practical approach to pharmaceutical policy. World Bank Publications; 2010.
7. Quality management of complaints and recalls of pharmaceuticals as per global GMPS. [Internet]. pharmatutor.org [cited 2024 Nov 10]. Available from:
http://www.pharmatutor.org/articles/qualitymanagement-of-complaints-and-recall-of-pharmaceuticals-asper-global-gmp
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
